Kim, S.J.; Ryu, K.J.; Park, B.; Yoon, S.E.; Cho, J.; Park, Y.; Kim, W.S.
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma. Cancers 2022, 14, 5618.
https://doi.org/10.3390/cancers14225618
AMA Style
Kim SJ, Ryu KJ, Park B, Yoon SE, Cho J, Park Y, Kim WS.
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma. Cancers. 2022; 14(22):5618.
https://doi.org/10.3390/cancers14225618
Chicago/Turabian Style
Kim, Seok Jin, Kyung Ju Ryu, Bon Park, Sang Eun Yoon, Junhun Cho, Yoon Park, and Won Seog Kim.
2022. "Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma" Cancers 14, no. 22: 5618.
https://doi.org/10.3390/cancers14225618
APA Style
Kim, S. J., Ryu, K. J., Park, B., Yoon, S. E., Cho, J., Park, Y., & Kim, W. S.
(2022). Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma. Cancers, 14(22), 5618.
https://doi.org/10.3390/cancers14225618